# Vision Translation Brief – Maya Chen / ClaraVision  

---  

## 1. FOUNDER IDENTITY  - **Name:** Maya Chen  
- **Company:** ClaraVision  
- **Domain:** Medical imaging (MRI/CT)  
- **One‑sentence vision:** *ClaraVision is building a HIPAA‑compliant, federated‑learning anomaly‑detection engine that runs natively inside hospital PACS networks, turning every scan into a real‑time safety net that reduces missed pathologies and creates a proprietary data flywheel across institutions.*  

---  

## 2. VISION TRANSLATION  

| Perspective | Description | Evidence from profile |
|-------------|-------------|-----------------------|
| **What the founder believes they are building** | A production‑grade, federated anomaly‑detection service that learns continuously from de‑identified MRI/CT data across multiple hospitals, delivering sub‑second inference at the point of care and generating a defensible data moat. | “twelve‑month goal: Deploy anomaly detection model in 3 hospital networks with federated learning across sites”; “investor narrative: Proprietary data flywheel across hospital networks creates defensible moat”. |
| **What the engineering team is actually building** | A prototype PyTorch/MONAI model trained on a single‑site dataset, containerized and stored in AWS S3, with no federated learning pipeline, no on‑premise inference service, and HIPAA controls only loosely addressed (e.g., relying on AWS S3 encryption without Business Associate Agreement). | “current_stack: PyTorch, MONAI, AWS S3”; “primary_challenge: Model stalled at prototype; GCP credits unactivated”. |
| **The gap** | **Scope & architecture:** Founder wants a multi‑site federated learning loop with on‑premise inference; engineering is delivering a single‑site, cloud‑storage prototype. <br>**Operational readiness:** Missing HIPAA‑BAA, no model serving layer (NIM/Triton), no CI/CD for model updates across hospitals. <br>**Incentive mismatch:** Engineering sees the task as “get a model working”; founder sees it as “launch a regulated, continuously improving service”. |  |

---  

## 3. NVIDIA STACK RECOMMENDATION  

| NVIDIA Tool | Why it fits ClaraVision’s use case | How it closes the gap |
|-------------|-----------------------------------|-----------------------|
| **NVIDIA FLARE** (Federated Learning Application Runtime) | Provides a secure, HIPAA‑ready framework for cross‑site model aggregation without moving raw DICOM data. | Enables the federated learning loop founder envisions; integrates with existing MONAI pipelines. |
| **NVIDIA MONAI Deploy** (part of Clara Train) | Packages MONAI research code into a clinical‑grade inference container with DICOM‑web support, versioned model bundles, and Helm charts for on‑prem K8s. | Moves prototype from a notebook to a deployable, version‑controlled service that can be rolled out to each hospital’s PACS. |
| **NVIDIA Triton Inference Server** (exposed via **NIM** – NVIDIA Inference Microservices) | Optimized GPU inference with dynamic batching, model versioning, and HTTPS/TLS endpoints; can be wrapped in a NIM for zero‑code deployment. | Provides the low‑latency inference layer needed for real‑time anomaly flagging inside the hospital network. |
| **NVIDIA AI Enterprise** (includes CUDA, cuDNN, TensorRT, NCCL) | Guarantees certified drivers, security patches, and enterprise support—required for HIPAA‑regulated environments. | Supplies the GPU compute foundation and ensures compliance‑ready software stack. |
| **NVIDIA Clara Guardian** (optional) | Edge‑hardened SDK for securing medical‑device data pipelines; can be used to enforce de‑identification before data leaves the scanner. | Adds an extra layer of HIPAA safeguard for incoming DICOM streams. |

### Deployment Architecture  
- **Hybrid on‑premise / private cloud:** Each hospital runs a small Kubernetes cluster (e.g., Rancher on VMware vSphere or bare‑metal) inside its network.  
- **Data never leaves the site:** DICOM streams are ingested via a Clara Guardian‑sidecar that performs de‑identification, then forwarded to the MONAI Deploy inference pod.  
- **Federated aggregation:** A central **FLARE** coordinator (hosted in a VPC with a signed BAA, or in a air‑gapped admin site) orchestrates model updates; only encrypted model weights travel between sites.  
- **Model serving:** Triton/NIM serves the latest model version; health‑checks and Prometheus metrics exposed via ServiceMonitor.  

### Compliance Considerations (HIPAA)  
- **BAA:** NVIDIA AI Enterprise and NVIDIA Clara products are covered under NVIDIA’s Business Associate Agreement; ensure the signed BAA is in place before any PHI touches GPU memory.  
- **Encryption‑at‑rest & in‑transit:** Use LUKS‑encrypted disks for persistent volumes; enforce TLS 1.3 for all inter‑service communication (FLARE, Triton, DICOMweb).  
- **Audit logging:** Enable Kubernetes audit logs and NVIDIA DCGM metrics; forward to a SIEM (e.g., Splunk) with retention ≥6 years.  
- **Access control:** RBAC + OIDC (Azure AD or Okta) scoped to the minimum necessary; no default `admin` tokens in containers.  
- **De‑identification:** Clara Guardian or custom MONAI transforms strip PHI tags before any data enters the training/federated pipeline.  

---  

## 4. GRAY SPINE INFRASTRUCTURE  

| Layer | Specific Recommendation | Rationale |
|-------|--------------------------|-----------|
| **GPU Compute Layer** | NVIDIA A100 40 GB (or A100 80 GB if budget allows) – 2 GPUs per hospital node (one for inference, one for local federated training). | A100 Tensor Cores give >10× speedup for 3D CNN MONAI models; sufficient memory for whole‑volume patches. |
| **CUDA / CUDA‑X Libraries** | CUDA 12.2, cuDNN 8.9, TensorRT 8.6, NCCL 2.19, CUDA Math Library (cuBLAS, cuFFT). | Matches NVIDIA AI Enterprise 2024 baseline; ensures kernel compatibility with MONAI Deploy containers. |
| **Framework** | **MONAI** (0.14+) for data transforms & model definition; **MONAI Deploy** for packaging; **NVIDIA FLARE 2.3** for federated learning orchestration. | MONai provides medical‑image‑specific pipelines; Deploy turns research into a Helm chart; FLARE handles secure cross‑site aggregation. |
| **Inference Layer** | **Triton Inference Server** exposed via **NIM** (NVIDIA Inference Microservice) – containerized with Helm chart `triton-inference-server`. | Triton’s dynamic batching and model‑repository versioning meet real‑time latency (<200 ms per 3D volume) and allow A/B testing of model versions. |
| **Deployment Target** | On‑premise Kubernetes (v1.28+) running on VMware vSphere 8.0 or bare‑metal with NVIDIA GPU Operator; Helm releases for MONAI Deploy, Triton/NIM, and FLARE coordinator. | Keeps data inside the hospital firewall, satisfies HIPAA physical‑access controls, and enables scaling to additional sites via identical Helm charts. |

---  

## 5. OPEN QUESTIONS FOR FIRST MEETING  

| # | Question | What a Good Answer Looks Like | What a Concerning Answer Looks Like |
|---|----------|------------------------------|--------------------------------------|
| 1 | **“How do you plan to satisfy the HIPAA Business Associate Agreement requirement for any NVIDIA software that will process PHI?”** | Founder can cite NVIDIA’s signed BAA (or show they have initiated the BAA request), describe a data‑flow diagram where PHI never leaves the hospital VPC, and note encryption‑at‑rest/TLS‑in‑transit controls already audited by their compliance officer. | Vague answer like “We’ll encrypt the data” without mentioning BAA, or stating they’ll rely solely on AWS S3 encryption (which does not cover GPU processing). |
| 2 | **“What is the current end‑to‑end latency from DICOM arrival at the PACS to anomaly flag display, and what latency target do you need for clinical adoption?”** | Founder provides measured numbers (e.g., 2.3 s total, with 1.2 s for preprocessing, 0.8 s for inference, 0.3 s for UI) and a target ≤1 s, citing radiologist feedback or a pilot study. | No latency measurement, or answer that latency is “not important because we’ll batch process nightly”, indicating a misunderstanding of real‑time clinical use. |
| 3 | **“Describe the federated learning workflow you envision: what data stays local, what is shared, how often model aggregation occurs, and how you will verify model convergence across sites?”** | Detailed steps: (1) Local site runs MONAI training on nightly new scans, produces encrypted weight deltas via FLARE; (2) Deltas sent nightly to central FLARE coordinator; (3) Coordinator aggregates via FedAvg, returns updated global model; (4) Convergence monitored via validation AUC on a held‑out local set shared only as metrics, not raw data. | Answer that “we’ll just send raw scans to the cloud for training” or “we’ll average models after each scan”, showing lack of awareness of HIPAA limits and federated learning mechanics. |

---  

**Prepared for:** NVIDIA Inception Technical Advisor – Initial engagement with Maya Chen / ClaraVision.  
**Date:** 2025‑09‑24.  

---  
*All recommendations are specific to the stated vision, current stack, and compliance constraints. Generic platitudes have been omitted.*